PL2772490T3 - Aminoalkilo-podstawiona pochodna n-tienylobenzamidu - Google Patents
Aminoalkilo-podstawiona pochodna n-tienylobenzamiduInfo
- Publication number
- PL2772490T3 PL2772490T3 PL12844048.4T PL12844048T PL2772490T3 PL 2772490 T3 PL2772490 T3 PL 2772490T3 PL 12844048 T PL12844048 T PL 12844048T PL 2772490 T3 PL2772490 T3 PL 2772490T3
- Authority
- PL
- Poland
- Prior art keywords
- aminoalkyl
- thienyl
- substituted
- benzamide derivative
- benzamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- C07D333/80—Seven-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
- C07F9/655354—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011236533 | 2011-10-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2772490T3 true PL2772490T3 (pl) | 2016-11-30 |
Family
ID=48167891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12844048.4T PL2772490T3 (pl) | 2011-10-27 | 2012-10-25 | Aminoalkilo-podstawiona pochodna n-tienylobenzamidu |
Country Status (16)
Country | Link |
---|---|
US (1) | US9062032B2 (pl) |
EP (1) | EP2772490B1 (pl) |
JP (2) | JP2013107880A (pl) |
KR (1) | KR101941048B1 (pl) |
CN (1) | CN103906741B (pl) |
AR (1) | AR088563A1 (pl) |
AU (1) | AU2012329913A1 (pl) |
CA (1) | CA2853688C (pl) |
EA (1) | EA023955B1 (pl) |
ES (1) | ES2585415T3 (pl) |
IL (1) | IL232230A0 (pl) |
IN (1) | IN2014CN03130A (pl) |
MX (1) | MX342521B (pl) |
PL (1) | PL2772490T3 (pl) |
TW (1) | TW201323419A (pl) |
WO (1) | WO2013062065A1 (pl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3150582A1 (en) | 2012-10-02 | 2017-04-05 | Gilead Sciences, Inc. | Inhibitors of histone demethylases |
US9499553B2 (en) | 2013-03-13 | 2016-11-22 | Chugai Seiyaku Kabushiki Kaisha | Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same |
SI2975030T1 (sl) | 2013-03-13 | 2020-10-30 | Chugai Seiyaku Kabushiki Kaisha | Derivat dihidropiridazin-3,5-diona |
TWI594975B (zh) * | 2013-04-24 | 2017-08-11 | 第一三共股份有限公司 | 二羧酸化合物 |
SG11201600891UA (en) | 2013-08-08 | 2016-03-30 | Galapagos Nv | Thieno[2,3-c]pyrans as cftr modulators |
WO2015064532A1 (ja) * | 2013-10-30 | 2015-05-07 | 第一三共株式会社 | モルホリン化合物 |
WO2015153498A1 (en) * | 2014-03-31 | 2015-10-08 | Epitherapeutics, Aps | Inhibitors of histone demethylases |
WO2016026372A1 (zh) * | 2014-08-22 | 2016-02-25 | 江苏恒瑞医药股份有限公司 | 噻吩并环烷基或噻吩并杂环基类衍生物、其制备方法及其在医药上的应用 |
CN107072993B (zh) | 2014-09-12 | 2021-02-12 | 中外制药株式会社 | 含有钠依赖性磷酸转运蛋白抑制剂的药物 |
ES2864277T3 (es) | 2014-09-26 | 2021-10-13 | Daiichi Sankyo Co Ltd | Sal de compuestos de ácido dicarboxílico |
CN105524053B (zh) * | 2014-10-19 | 2020-06-05 | 广东东阳光药业有限公司 | 四氢苯并噻吩化合物 |
TW201700458A (zh) | 2015-04-24 | 2017-01-01 | 第一三共股份有限公司 | 二羧酸化合物之製法 |
CN107082773B (zh) * | 2016-02-16 | 2020-07-28 | 江苏恒瑞医药股份有限公司 | 一种肠2b型磷酸钠协同转运蛋白抑制剂的硫酸盐及其结晶形式 |
ES2830444T3 (es) * | 2016-08-15 | 2021-06-03 | Lilly Co Eli | Derivados de tiofeno condensado útiles como inhibidores de NaPi-IIb |
JOP20190080A1 (ar) | 2016-10-14 | 2019-04-11 | Bayer Pharma AG | مركبات مشتقة من 6-(1h-بيرازول-1-يل) بيريميدين-4- أمين مستبدل واستخداماتها |
CN109422723B (zh) * | 2017-08-25 | 2021-02-23 | 江苏恒瑞医药股份有限公司 | 一种肠2b型磷酸钠协同转运蛋白抑制剂的晶型及其制备方法 |
CA3221186A1 (en) | 2021-06-08 | 2022-12-15 | Kenichi Sakai | Formulation containing dihydropyridazine-3,5-dione derivative |
AR126060A1 (es) | 2021-06-08 | 2023-09-06 | Chugai Pharmaceutical Co Ltd | Método para producir derivado de dihidropiridazin-3,5-diona |
WO2023203254A2 (en) | 2022-04-22 | 2023-10-26 | Fundamental Pharma Gmbh | Effective means to modulate nmda receptor-mediated toxicity |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002213048A1 (en) | 2000-10-05 | 2002-04-15 | Smith Kline Beecham Corporation | Phosphate transport inhibitors |
JP2007131532A (ja) * | 2001-09-28 | 2007-05-31 | Kirin Brewery Co Ltd | 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬 |
JPWO2003048134A1 (ja) | 2001-12-05 | 2005-04-14 | 日本たばこ産業株式会社 | トリアゾール化合物及びその医薬用途 |
EP1614676A4 (en) | 2003-03-27 | 2009-03-25 | Kirin Pharma Kk | PHOSPHORUS TRANSPORT IN VIVO INHIBITOR COMPOUND AND MEDICAMENT CONTAINING THE SAME |
WO2006093518A2 (en) | 2004-06-25 | 2006-09-08 | Apath, Llc | Thienyl compounds for treating virus-related conditions |
CA2579089A1 (en) | 2004-08-30 | 2006-03-09 | Government Of The United States Of America As Represented By The Secreta Ry Department Of Health And Human Services | Inhibition of viruses using rnase h inhibitors |
WO2006044826A2 (en) | 2004-10-20 | 2006-04-27 | Compass Pharmaceuticals Llc | Thiophens and their use as anti-tumor agents |
KR101343399B1 (ko) * | 2008-01-08 | 2013-12-19 | 퍼듀 퍼머 엘피 | 통증 치료를 위한 카나비노이드 수용체에 대한 리간드로서의 프롤린 유사체 |
JP5617919B2 (ja) | 2010-04-28 | 2014-11-05 | アステラス製薬株式会社 | テトラヒドロベンゾチオフェン化合物 |
JP5823514B2 (ja) | 2010-07-07 | 2015-11-25 | アーデリクス,インコーポレーテッド | リン酸輸送を阻害する化合物及び方法 |
WO2012006473A1 (en) | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
EP2590965B1 (en) | 2010-07-07 | 2016-04-20 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
EP2590510B1 (en) | 2010-07-07 | 2016-09-28 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
EP2591354B1 (en) | 2010-07-07 | 2016-09-07 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
-
2012
- 2012-10-25 EA EA201490875A patent/EA023955B1/ru not_active IP Right Cessation
- 2012-10-25 AU AU2012329913A patent/AU2012329913A1/en not_active Abandoned
- 2012-10-25 WO PCT/JP2012/077660 patent/WO2013062065A1/ja active Application Filing
- 2012-10-25 KR KR1020147014256A patent/KR101941048B1/ko active IP Right Grant
- 2012-10-25 CN CN201280053147.6A patent/CN103906741B/zh active Active
- 2012-10-25 MX MX2014005090A patent/MX342521B/es active IP Right Grant
- 2012-10-25 EP EP12844048.4A patent/EP2772490B1/en active Active
- 2012-10-25 JP JP2012236135A patent/JP2013107880A/ja active Pending
- 2012-10-25 PL PL12844048.4T patent/PL2772490T3/pl unknown
- 2012-10-25 ES ES12844048.4T patent/ES2585415T3/es active Active
- 2012-10-25 CA CA2853688A patent/CA2853688C/en active Active
- 2012-10-25 IN IN3130CHN2014 patent/IN2014CN03130A/en unknown
- 2012-10-25 JP JP2013540835A patent/JP6020460B2/ja active Active
- 2012-10-25 TW TW101139423A patent/TW201323419A/zh unknown
- 2012-10-25 US US14/354,086 patent/US9062032B2/en active Active
- 2012-10-26 AR ARP120104035A patent/AR088563A1/es unknown
-
2014
- 2014-04-24 IL IL232230A patent/IL232230A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA201490875A1 (ru) | 2014-09-30 |
WO2013062065A1 (ja) | 2013-05-02 |
BR112014010169A2 (pt) | 2017-04-25 |
MX342521B (es) | 2016-10-03 |
CA2853688C (en) | 2018-06-12 |
JP2013107880A (ja) | 2013-06-06 |
KR101941048B1 (ko) | 2019-01-22 |
KR20140096322A (ko) | 2014-08-05 |
MX2014005090A (es) | 2015-02-12 |
CN103906741B (zh) | 2016-01-20 |
EP2772490A1 (en) | 2014-09-03 |
IN2014CN03130A (pl) | 2015-07-03 |
US9062032B2 (en) | 2015-06-23 |
US20150031727A1 (en) | 2015-01-29 |
IL232230A0 (en) | 2014-06-30 |
EP2772490A4 (en) | 2015-01-21 |
TW201323419A (zh) | 2013-06-16 |
JP6020460B2 (ja) | 2016-11-02 |
EA023955B1 (ru) | 2016-07-29 |
JPWO2013062065A1 (ja) | 2015-04-02 |
CA2853688A1 (en) | 2013-05-02 |
AR088563A1 (es) | 2014-06-18 |
AU2012329913A1 (en) | 2014-05-22 |
ES2585415T3 (es) | 2016-10-05 |
EP2772490B1 (en) | 2016-04-06 |
CN103906741A (zh) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20180646T1 (hr) | Dispiropirolidinski derivat | |
EP2772490A4 (en) | AMINO ALKYL SUBSTITUTED N-THIENYLBENZAMIDE DERIVATIVE | |
EP2777438A4 (en) | FIXING CORD OF COATING MATERIAL | |
HK1195557A1 (zh) | 苯甲酰胺 | |
HK1203926A1 (en) | Benzamide derivative | |
HK1192562A1 (zh) | 取代的苯甲酰胺衍生物 | |
EP2663331A4 (en) | NEW USES | |
EP2687531A4 (en) | TETRAHYDROCARBOLINE DERIVATIVE | |
EP2740730A4 (en) | DIBENZOOXEPINE DERIVATIVE | |
ZA201401983B (en) | Phenyl derivative | |
HK1176061A1 (en) | Novel benzamide derivatives | |
GB201119167D0 (en) | Novel bachteriophages | |
IL233001A0 (en) | New iso-ergoline histories | |
HK1198033A1 (zh) | -雜環取代醯胺衍生物 | |
EP2716258A4 (en) | INTRASTOMAL SEGMENT | |
EP2716626A4 (en) | benzylamine | |
GB201121669D0 (en) | Formula 1 - 2050 | |
GB201121656D0 (en) | Formula 1 - 2050 | |
DK201200158A (en) | Pose i pose | |
GB201107854D0 (en) | Novel 5-hydroxy-5-aryl-pyrrol-2-ones |